PELIZZARO, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 1.026
EU - Europa 330
AS - Asia 229
AF - Africa 6
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.597
Nazione #
US - Stati Uniti d'America 1.018
IT - Italia 195
SG - Singapore 144
CN - Cina 67
FR - Francia 31
DE - Germania 16
FI - Finlandia 16
GB - Regno Unito 16
SE - Svezia 15
NL - Olanda 9
MX - Messico 8
CH - Svizzera 6
IE - Irlanda 6
JP - Giappone 6
PL - Polonia 5
BE - Belgio 4
HK - Hong Kong 4
BR - Brasile 3
EG - Egitto 3
IN - India 3
RO - Romania 3
AT - Austria 2
DK - Danimarca 2
LS - Lesotho 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AU - Australia 1
IR - Iran 1
MD - Moldavia 1
MT - Malta 1
RU - Federazione Russa 1
TW - Taiwan 1
UA - Ucraina 1
UG - Uganda 1
VN - Vietnam 1
Totale 1.597
Città #
Fairfield 169
Singapore 120
Chandler 111
Ashburn 73
Santa Clara 64
Woodbridge 59
Houston 51
Boardman 50
Cambridge 47
Padova 41
Seattle 36
Wilmington 29
San Diego 27
Medford 25
Princeton 25
Beijing 19
Ann Arbor 18
New York 18
Roxbury 15
Arezzo 13
Des Moines 12
Helsinki 12
Milan 12
Guangzhou 10
Verona 10
Cagliari 9
Bologna 7
London 6
Lausanne 5
Rome 5
Shanghai 5
Dublin 4
Gdansk 4
Lappeenranta 4
Metepec 4
Mexico City 4
Tokyo 4
Trieste 4
Changsha 3
Deiva Marina 3
Hong Kong 3
Isola di Capo Rizzuto 3
Messina 3
Mogliano Veneto 3
Nanjing 3
Palermo 3
São Paulo 3
Treviso 3
Zwalm 3
Ancona 2
Bucharest 2
Cairo 2
Cingoli 2
Cinisello Balsamo 2
Falconara Marittima 2
Frankfurt am Main 2
Grassobbio 2
Hounslow 2
Jinan 2
Kilburn 2
Legnaro 2
Limatola 2
Los Angeles 2
Lyon 2
Manila 2
Marseille 2
Maseru 2
Miyazaki 2
Montebello Vicentino 2
Naples 2
Oderzo 2
Paris 2
Pisa 2
Pune 2
Rovigo 2
San Martino Buon Albergo 2
Sassari 2
Stockholm 2
Trento 2
Venice 2
Vienna 2
Amsterdam 1
Arce 1
Banha 1
Bari 1
Bassano del Grappa 1
Bethesda 1
Bilston 1
Brescia 1
Buenos Aires 1
Casier 1
Catania 1
Chisinau 1
Chiswick 1
Genoa 1
Ho Chi Minh City 1
Induno Olona 1
Kampala 1
Kharkiv 1
Las Vegas 1
Totale 1.247
Nome #
Capecitabine in advanced hepatocellular carcinoma: A multicenter experience 137
Monofocal hepatocellular carcinoma: How much does size matter? 104
SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differences 85
Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens 83
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 69
Pattern of macrovascular invasion in hepatocellular carcinoma 55
Liquid biopsy in hepatocellular carcinoma: Where are we now? 51
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 50
The risk of malignancies in celiac disease—A literature review 49
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 47
Boost: A phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function 46
Autoimmune Atrophic Gastritis: The Role of miRNA in Relation to Helicobacter Pylori Infection 45
Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients 44
Eosinophilic esophagitis and biologics 43
Machine learning in liver transplantation: a tool for some unsolved questions? 43
Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma 43
Letter: is female sex really associated with better prognosis in hepatocellular carcinoma? 39
Circulating microrna-21 and microrna-122 as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization 38
Coffee and hepatocellular carcinoma: Epidemiologic evidence and biologic mechanisms 37
Systemic therapies for hepatocellular carcinoma: An evolving landscape 36
BIOMARCATORI CIRCOLANTI E FATTORI CLINICI ASSOCIATI CON LA PROGNOSI NEI PAZIENTI CON CARCINOMA EPATOCELLULARE 35
Management of hepatocellular carcinoma recurrence after liver transplantation 33
Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis 30
Eosinophilic esophagitis: from pathophysiology to management 29
Treatment of hepatocellular carcinoma with immune checkpoint inhibitors and applicability of first-line atezolizumab/bevacizumab in a real-life setting 29
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 26
Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications 25
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC 24
Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies 24
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 24
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 19
Gastric cancer screening in Western countries: A call to action 19
Crosstalk between MicroRNAs and Oxidative Stress in Coeliac Disease 19
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization 19
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 18
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance 16
Alcoholic Etiology, Severity of Liver Disease, and Post-Transplant Adherence Are Correlated with Worse Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates 15
Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges 14
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma 14
Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role? 14
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison 13
A rare cause of painful hepatomegaly 12
Multiple hepatic cysts in an adult male 10
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 8
Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0 8
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 8
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 7
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 6
Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists 6
Totale 1.668
Categoria #
all - tutte 11.858
article - articoli 11.708
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.566


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 2 5 4 5 5 2 2
2020/2021184 2 3 34 0 1 2 5 41 14 12 6 64
2021/2022371 9 22 11 16 10 41 53 45 18 20 42 84
2022/2023283 62 9 26 26 42 32 6 16 33 5 21 5
2023/2024372 21 40 41 22 13 45 71 13 17 20 31 38
2024/2025386 12 96 63 46 130 39 0 0 0 0 0 0
Totale 1.668